利用循环肿瘤 DNA 作为 Efortumab Vedotin 和 Pembrolizumab 治疗转移性尿路上皮癌病例的反应生物标记物

{"title":"利用循环肿瘤 DNA 作为 Efortumab Vedotin 和 Pembrolizumab 治疗转移性尿路上皮癌病例的反应生物标记物","authors":"Sree M Lanka, Albert Jang, Pedro Barata","doi":"10.53876/001c.90317","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"62 16","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Utilization of Circulating Tumor DNA as a Biomarker of Response in a Case of Metastatic Urothelial Carcinoma Treated with Efortumab Vedotin and Pembrolizumab\",\"authors\":\"Sree M Lanka, Albert Jang, Pedro Barata\",\"doi\":\"10.53876/001c.90317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":237891,\"journal\":{\"name\":\"International Journal of Cancer Care and Delivery\",\"volume\":\"62 16\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer Care and Delivery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53876/001c.90317\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer Care and Delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53876/001c.90317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}